MOG and myeloid sarcoma: In this review, we provide an updated overview of the clinical, radiological and biochemical characteristics of MOG-antibody associated disease, discuss the prognosis, highlight the differences from MS and AQP4-NMOSD, and explore the acute and preventive therapeutic options.